Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. VINGE ADVISES CREADES IN CONNECTION WITH ITS LISTING ON NASDAQ OMX STOCKHOLM’S MAIN MARKET
Mandate

VINGE ADVISES CREADES IN CONNECTION WITH ITS LISTING ON NASDAQ OMX STOCKHOLM’S MAIN MARKET

December 05, 2013

Creades AB (publ) (NASDAQ OMX First North) has been approved for listing on NASDAQ OMX’s main market. The first day of trading was 6 December 2013.

Vinge’s team primarily consisted of partner Erik Sjöman and associates Jo-Anna Nordström, Christian Lindhé and Rikard Lindahl. Associates Maria Schultzberg and Maria Doeser advised in relation to tax matters.

Related

Vinge has advised Verisure in connection with its IPO on Nasdaq Stockholm

 Vinge has advised Verisure plc (“Verisure”) in connection with its IPO on Nasdaq Stockholm. Following the publication of the prospectus on 29 September 2025, trading in Verisure’s shares commenced today, 8 October 2025.
October 08, 2025

Vinge has acted for Advania on the acquisition of smartvokat

smartvokat GmbH, a German-based consultancy specialising in digital transformation within the legal, risk, and compliance domains, will become part of Advania’s business unit Transformation & Automation.
October 08, 2025

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025